Gland Pharma net profit jumps over two-fold to Rs 192 crore in Q4 Ruchika Sharma23 May 2024 2:53 PM ISTNew Delhi: Gland Pharma announced a consolidated profit after tax (PAT) increase of over two-fold, reaching Rs 192 crore in the March...
Granules India Promoter sells 3.09 pecent stake for Rs 304 crore Ruchika Sharma23 May 2024 12:47 PM ISTHyderabad: Krishna Prasad Chigurupati, a promoter of Granules India, has sold a 3.09 percent stake in the company for Rs 304 crore through an...
Alvotech, Dr Reddy's collaborate for commercialization of AVT03 in US, Europe and UK Ruchika Sharma23 May 2024 12:16 PM ISTHyderabad: Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
Laurus Lab Gets CDSCO Panel Nod To Manufacture and Market Sodium Phenylbutyrate Powder Dr. Divya Colin22 May 2024 6:00 PM ISTNew Delhi: Noting that urea cycle disorder is a very rare disease and there are unmet medical needs in the country, the Subject Expert Committee (SEC)...
Zydus Lifesciences gets USFDA nod for asthma drug Theophylline ER Ruchika Sharma22 May 2024 3:45 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Theophylline...
Indoco Remedies gets USFDA okay for Pregabalin capsules Ruchika Sharma22 May 2024 2:52 PM ISTPregabalin is used for Neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, Postherpetic neuralgia and...
Cipla bags USFDA nod for Lanreotide Injection for Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors Ruchika Sharma22 May 2024 12:35 PM ISTCipla's Lanreotide injection is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors.
USFDA approves Strides Pharma Global stomach ulcer treatment drug Ruchika Sharma22 May 2024 11:30 AM ISTSucralfate is used to treat stomach ulcers, gastroesophageal reflux disease, radiation proctitis, and stomach inflammation and to prevent stress...
CDSCO Panel grants Novartis Protocol Amendment Proposal to study Remibrutinib in Chronic Spontaneous Urticaria Dr. Divya Colin21 May 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Roche gets USFDA Breakthrough Therapy Designation for Inavolisib for breast cancer with mutation Ruchika Sharma21 May 2024 2:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an...
SII ships first set of R21/Matrix-M Malaria Vaccine doses to Africa Ruchika Sharma21 May 2024 12:30 PM ISTPune: Serum Institute of India, the world's largest manufacturer of vaccines by number of doses, on Monday shipped its first set of R21/Matrix-M...
Biocon Biologics forays into US Ophthalmology market with USFDA nod for Yesafili Ruchika Sharma21 May 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, today announced that the U.S....
